Reducing antimicrobial use in livestock alone may be not sufficient to reduce antimicrobial resistance among human Campylobacter infections: an ecological study in the Netherlands

Epidemiol Infect. 2024 Nov 27:152:e148. doi: 10.1017/S0950268824001511.

Abstract

Reducing antimicrobial use (AMU) in livestock may be one of the keys to limit the emergence of antimicrobial resistance (AMR) in bacterial populations, including zoonotic pathogens. This study assessed the temporal association between AMU in livestock and AMR among Campylobacter isolates from human infections in the Netherlands between 2004 - 2020. Moreover, the associations between AMU and AMR in livestock and between AMR in livestock and AMR in human isolates were assessed. AMU and AMR data per antimicrobial class (tetracyclines, macrolides and fluoroquinolones) for Campylobacter jejuni and Campylobacter coli from poultry, cattle, and human patients were retrieved from national surveillance programs. Associations were assessed using logistic regression and the Spearman correlation test. Overall, there was an increasing trend in AMR among human C. jejuni/coli isolates during the study period, which contrasted with a decreasing trend in livestock AMU. In addition, stable trends in AMR in broilers were observed. No significant associations were observed between AMU and AMR in domestically produced broilers. Moderate to strong positive correlations were found between the yearly prevalence of AMR in broiler and human isolates. Reducing AMU in Dutch livestock alone may therefore not be sufficient to tackle the growing problem of AMR in Campylobacter among human cases in the Netherlands. More insight is needed regarding the population genetics and the evolutionary processes involved in resistance and fitness among Campylobacter.

Keywords: C. jejuni; Campylobacter coli; antimicrobial resistance; antimicrobial use; one health.

MeSH terms

  • Animals
  • Anti-Bacterial Agents* / pharmacology
  • Anti-Bacterial Agents* / therapeutic use
  • Campylobacter Infections* / drug therapy
  • Campylobacter Infections* / epidemiology
  • Campylobacter Infections* / microbiology
  • Campylobacter Infections* / veterinary
  • Campylobacter coli / drug effects
  • Campylobacter coli / isolation & purification
  • Campylobacter jejuni* / drug effects
  • Campylobacter jejuni* / isolation & purification
  • Cattle
  • Cattle Diseases / drug therapy
  • Cattle Diseases / epidemiology
  • Cattle Diseases / microbiology
  • Chickens / microbiology
  • Drug Resistance, Bacterial*
  • Humans
  • Livestock* / microbiology
  • Netherlands / epidemiology
  • Poultry / microbiology
  • Poultry Diseases / drug therapy
  • Poultry Diseases / epidemiology
  • Poultry Diseases / microbiology

Substances

  • Anti-Bacterial Agents